Grant Life Sciences, Inc. (fka GLIF)

[machninetwo]

Potential is unreal, no doubt

The clinincal trials are in progress and going well.

Also this year, Grant Life Sciences announced that it has agreements in place with two distinguished cervical cancer researchers--Mark Dodson, M.D., and Andrew P. Soisoon, M.D.--to determine the clinical utility of its cervical cancer diagnostic. Dr. Dodson is Associate Professor and Division Chief of Gynecologic Oncology at the University of Utah School of Medicine. He also has been with the Huntsman Cancer Institute since its inception. Dr. Soisoon is a Professor in the Department of Obstetrics and Gynecology at the University of Utah School of Medicine, a Huntsman Cancer Institute researcher, and is the new primary investigator with the Gynecologic Oncology Group, a National Cancer Institute-funded nonprofit organization that promotes excellence in quality and integrity of clinical and basic scientific research. These physicians will be Co-Principal Investigators in a newly IRB-approved clinical study through Intermountain Health Care, recently named the nation's top health care system according to a study of 582 systems by Modern Healthcare magazine and Verispan Research, to determine the clinical utility of Grant Life Sciences' serum-based diagnostic test for cervical dysplasia and cancer.



http://www.medtechinsight.com/cancerbloodtest.pdf

Peace